WASATCH ADVISORS INC 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 12:48 pm Sale |
2024-11-14 | 13G | Nurix Therapeutics, Inc. NRIX |
WASATCH ADVISORS INC | 708,377 1.100% |
-2,041,368 (-74.24%) |
Filing |
| 2024-02-09 1:56 pm Purchase |
2024-02-09 | 13G | Nurix Therapeutics, Inc. NRIX |
WASATCH ADVISORS INC | 2,749,745 5.700% |
211,113 (+8.32%) |
Filing |
| 2023-02-08 1:07 pm Purchase |
2023-02-08 | 13G | Nurix Therapeutics, Inc. NRIX |
WASATCH ADVISORS INC | 2,538,632 5.400% |
2,538,632 (New Position) |
Filing |